FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Anemia news from FiercePharma

News

NC hospital nixes drug-sample handouts

While drugmakers and the Massachusetts legislature duke it out over the "no pharma freebies" Read more...
Tags: Anemia   pharma gifts  

J&J laying off 400 in marketing overhaul

With Procrit under siege, Johnson & Johnson wants to divert its promotional efforts elsewhere--a strategy that will lead to some 400 job cuts in its sales-and-marketing ranks. The company told Read more...

Roche appeals Mircera injunction

Roche is appealing to a higher power on Mircera. The Swiss drugmaker is appealing a lower court ruling barring Read more...

Grassley: Amgen doc rebates skyrocket

Another day, another Grassley letter. You'll recall that earlier this week, Sen. Chuck Grassley demanded documents from Amgen relating to the company's promotions of its anemia drugs. Now, Grassley Read more...
Tags: Aranesp   Amgen   Anemia  

Congress probes Amgen, J&J promos

Did Amgen and Johnson & Johnson over-promote their anemia drugs? Congress is asking the companies for documents detailing their advertising and promotions, including a "bundling" discount Amgen Read more...
Tags: Aranesp   Amgen   Procrit   Anemia   Medicare  

Court sends Mircera case to ITC

Another chapter in what's becoming a long Mircera saga: A federal appeals court ruled that Roche could import the anemia drug so long as it wasn't for sale--but sent the case back to the Read more...
Tags: Tarceva   Amgen   Mircera   Roche   lung cancer   Anemia  

Amgen: Mircera deal would set precedent

Should he or shouldn't he? The judge weighing the case of Amgen v. Roche is getting a lot of unsolicited advice on whether to allow Roche's anemia med Mircera onto the market. Last year, a jury ruled Read more...
Tags: Epogen   Aranesp   Amgen   Mircera   Roche   Anemia  

ALSO NOTED: Roche accepts judge's deal on Mircera; Pharma stocks weathered yesterday's craziness;

> Breaking news: Roche said it agreed to a judge's conditions for its launch of the anemia drug Mircera, which Amgen had attacked for patent infringement; the conditions include a higher royalty Read more...
Tags: Amgen   Anemia  

J&J hikes CEO's pay to $25.1M

Another day, another CEO pay raise. Johnson & Johnson honcho Bill Weldon (photo) nabbed a 22 percent hike in compensation in Read more...
Tags: Procrit   Astrazeneca   Amgen   Merck   Anemia